Literature DB >> 25389746

Rosai-dorfman disease diagnosed because of bilateral choroidal masses.

Yoreh Barak1, Melissa G Tong, Todd J Purkiss, Shlomit Schaal.   

Abstract

PURPOSE: To describe a case of bilateral choroidal masses leading to the diagnosis of Rosai-Dorfman disease.
METHOD: Case report. Color photographs, fluorescein angiography, autofluorescence, indocyanine green angiography, and high-definition optical coherence tomography imaging of both eyes and computed tomography and biopsy of pelvis mass were performed. A 47-year-lady presented with unknown choroidal masses in both eyes. She had no visual complaints. Her medical history was noncontributory.
RESULTS: Workup included a computed tomography of the chest and abdomen that demonstrated soft tissue masses in the renal pelvis bilaterally. A core needle biopsy from the renal mass demonstrated numerous histiocytoid that were positive for CD163 and S100 protein.
CONCLUSION: Based on this spectrum of findings, the diagnosis of Rosai-Dorfman disease was made. To date, the patient has been followed-up for 3 years without medical intervention and without visual deterioration. Careful follow-up is a reasonable management if patients are asymptomatic.

Entities:  

Year:  2012        PMID: 25389746     DOI: 10.1097/ICB.0b013e3182378dd8

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  3 in total

1.  Choroidal involvement in Rosai-Dorfman syndrome may be depicted and followed using enhanced depth imaging optical coherence tomography (EDI-OCT).

Authors:  Janelle Fassbender; Shlomit Schaal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

2.  Choroidal involvement in Rosai-Dorfman syndrome may be depicted and followed using enhanced depth imaging optical coherence tomography (EDI-OCT).

Authors:  Timothy William Isaacs; Tersia L Vermeulen; Dominic Spagnolo; Ben Amanuel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-01       Impact factor: 3.117

3.  Choroidal involvement in Rosai-Dorfman disease successfully treated with cobimetinib.

Authors:  Chiara Giuffrè; Giuseppe Giuffrè
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.